Driven by new product launches and focus on areas like women’s health care, cardiology and diabetes, German drug firm Merck KGaA today said its expects sales revenue to grow by 20 per cent in the next three years in India. The company that is present in both over-the-counter segment and prescription based medicines segment said it expects the two segments to drive growth equally.
